Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Ascelia Pharma AB (7ZA.F)

0.2075
-0.0560
(-21.25%)
At close: April 25 at 8:06:40 AM GMT+2
Loading Chart for 7ZA.F
  • Previous Close 0.2635
  • Open 0.2075
  • Bid 0.2180 x --
  • Ask 0.3585 x --
  • Day's Range 0.2075 - 0.2075
  • 52 Week Range 0.1110 - 1.0580
  • Volume 1,000
  • Avg. Volume 1,733
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 14, 2025 - May 19, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 7ZA.F

View More

Performance Overview: 7ZA.F

Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

7ZA.F
6.96%
OMX Stockholm 30 Index (^OMX)
2.26%

1-Year Return

7ZA.F
75.33%
OMX Stockholm 30 Index (^OMX)
3.90%

3-Year Return

7ZA.F
90.24%
OMX Stockholm 30 Index (^OMX)
18.35%

5-Year Return

7ZA.F
95.46%
OMX Stockholm 30 Index (^OMX)
60.29%

Compare To: 7ZA.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 7ZA.F

View More

Valuation Measures

Annual
As of 4/25/2025
  • Market Cap

    27.74M

  • Enterprise Value

    23.20M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    2.77

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 7ZA.F

View More

Company Insights: 7ZA.F

Research Reports: 7ZA.F

View More